Inhibition of adipose tissue lipase activity following administration of vasopressin.
D000273:Adipose Tissue / Q000032:analysis / Q000201:enzymology*; D002001:Adipose Tissue, Brown / Q000032:analysis / Q000201:enzymology; D000818:Animals; D003864:Depression, Chemical; D004789:Enzyme Activation / Q000187:drug effects; D005230:Fatty Acids, Nonesterified / Q000032:analysis; D005990:Glycerol / Q000032:analysis; D007267:Injections; D008049:Lipase / Q000378:metabolism*; D008074:Lipoproteins / Q000378:metabolism; D008239:Lysine / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D014667:Vasopressins / Q000494:pharmacology*
D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D014667:Vasopressins; D008049:Lipase; D008239:Lysine; D005990:Glycerol; D009638:Norepinephrine